Date: 2011-09-21
Type of information: R&D agreement
Compound: acne vaccine and treatment
Company: Sanofi Pasteur (France) University of California, San Diego (USA)
Therapeutic area: Dermatological diseases - Infectious diseases
Type agreement: R&D
Action mechanism:
Disease: Acne vulgaris
Details: Sanofi Pasteur, the vaccines division of Sanofi has announced a research and development collaboration with the University of California, San Diego (UC San Diego) on an immunological approach to acne prevention and treatment targeting the specific neutralization of Propionibacterium acnes factors in inflammation. The agreement includes a two-year research collaboration with Dr. Chun-Ming Huang and his associates at UC San Diego School of Medicine for further research and development.
Financial terms: Financial terms of the agreement were not disclosed.
Latest news:
